Xcellerex, Inc. Secures $31,000,000 Series C Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6b79608f-e83c-48cb-942f-c2003e45e456&Preview=1 -
Date
10/11/2007 -
Company Name
Xcellerex, Inc. -
Mailing Address
170 Locke Drive Marlborough, MA 01752 -
Company Description
Xcellerex is revolutionizing the way biomolecules are developed, manufactured and commercialized.Xcellerex is built around a unique biomanufacturing platform that features the innovative application of single-use component technology.
-
Website
http://www.xcellerex.com -
Transaction Type
Venture Equity -
Transaction Amount
$31,000,000 -
Transaction Round
Series C -
Proceeds Purposes
“The financing will enable us to continue the development and commercialization of the FlexFactory model, initiate development of proprietary biomolecules using the FlexFactory and grow our bioreactor business,” said Joseph S. Zakrzewski, Chief Executive Officer of Xcellerex. -
M&A Terms
-
Venture Investor
VantagePoint Venture Partners -
Venture Investor
Kleiner Perkins Caufield & Byers
